PHARMACOECONOMIC ASSESSMENT OF APIXABAN VERSUS STANDARD OF CARE FOR THE PREVENTION OF STROKE IN ITALIAN NON-VALVULAR ATRIAL FIBRILLATION PATIENTS

被引：1
|
作者：
Pradelli, L. [1 ]
Calandriello, M. [2 ]
Di Virgilio, R. [3 ]
Bellone, M. [1 ]
Tubaro, M. [4 ]
机构：
[1] AdRes HE&OR, Turin, Italy
[2] Bristol Myers Squibb Srl, HE OR Unit, Rome, Italy
[3] Pfizer Pharmaceut Inc, Rome, Italy
[4] San Filippo Neri Hosp, Rome, Italy
来源：
VALUE IN HEALTH | 2014年 / 17卷 / 07期
关键词：
D O I：
10.1016/j.jval.2014.08.1427
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PCV83
引用
收藏
页码：A486 / A487
页数：2
相关论文
共 50 条
  • [31] Antithrombotic therapy for stroke prevention in non-valvular atrial fibrillation
    Alberts, Mark J.
    Eikelboom, John W.
    Hankey, Graeme J.
    LANCET NEUROLOGY, 2012, 11 (12): : 1066 - 1081
  • [32] New oral anticoagulants for the prevention of stroke in patients with non-valvular atrial fibrillation
    Bosch, Montserrat
    Llop, Roser
    Lalueza, Pilar
    del Mar Villar, Maria
    MEDICINA CLINICA, 2013, 140 (05): : 229 - 231
  • [33] Stroke prevention in patients with non-valvular atrial fibrillation: A current community perspective
    Enis, J
    JOURNAL OF CLINICAL NEUROSCIENCE, 1997, 4 (03) : 320 - 325
  • [34] Emerging oral anticoagulants for stroke prevention in patients with non-valvular atrial fibrillation
    Destephan, C.
    Waller, A. H.
    Patel, R. J.
    Dhruvakumar, S.
    Mazza, V.
    Gerula, C.
    Maher, J.
    Kaluski, E.
    MINERVA CARDIOANGIOLOGICA, 2012, 60 (04): : 425 - 431
  • [35] Economic evaluation of dabigatran for stroke prevention in patients with non-valvular atrial fibrillation
    Miguel, Luis Silva
    Rocha, Evangelista
    Ferreira, Jorge
    REVISTA PORTUGUESA DE CARDIOLOGIA, 2013, 32 (7-8) : 557 - 565
  • [36] Rivaroxaban for Stroke Prevention in Patients with Non-Valvular Atrial Fibrillation and Active Cancer
    Laube, Eva Simona
    Yu, Anthony
    Gupta, Dipti
    Miao, Yimei
    Samedy, Patrick
    Wills, Jonathan
    Harnicar, Stephen J.
    Soff, Gerald A.
    Mantha, Simon
    BLOOD, 2016, 128 (22)
  • [37] Real - world evidence of stroke prevention in patients with non-valvular atrial fibrillation
    Coleman, C.
    Antz, M.
    EUROPEAN HEART JOURNAL, 2016, 37 : 502 - 502
  • [38] Secondary prevention of stroke in patients with non-valvular atrial fibrillation: the clinicians' viewpoint
    Drozdova, E. A.
    RATIONAL PHARMACOTHERAPY IN CARDIOLOGY, 2014, 10 (02) : 179 - 183
  • [39] Cost Effectiveness of Apixaban Versus Aspirin for Stroke Prevention in Patients with Non-Valvular Atrial Fibrillation in Belgium (vol 34, pg 709, 2014)
    Kongnakorn, Thitima
    Lanitis, Tereza
    Annemans, Lieven
    Thijs, Vincent
    Marbaix, Sophie
    CLINICAL DRUG INVESTIGATION, 2014, 34 (10) : 753 - 753
  • [40] Economic evaluation of rivaroxaban versus acenocoumarol in the prevention of stroke in patients with non-valvular atrial fibrillation in Spain
    Rubio-Terres, C.
    Graefenhain De Codes, R.
    Rubio-Rodriguez, D.
    Evers, T.
    Grau, S.
    Espinos, B.
    Llorac, A.
    EUROPEAN HEART JOURNAL, 2016, 37 : 482 - 483
12345